-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701.O1.6 701. Experimental Transplantation: Basic and Translational: GVHD, Mucosal Immunology and the Microbiome

Symposia: Experimental Transplantation: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Apoptosis, Adult, Translational Research, Bioinformatics, GVHD, Immune mechanism, Diseases, Immune Disorders, Immunology, Metabolism, Computational biology, Biological Processes, Microbiome, Technology and Procedures, Study Population, Human, Animal model, Omics technologies
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Room 6B (San Diego Convention Center)
Moderators:
Mary Mansour Riwes, DO, University of Michigan and Daigo Hashimoto, MD, Hokkaido University
Disclosures:
Hashimoto: Astellas Pharma Inc. Japan: Honoraria; Janssen Pharmaceutical K.K.: Honoraria; Nippon Kayaku Co.,Ltd.: Honoraria; Novartis Japan: Honoraria; Eisai Co., Ltd.: Honoraria; Daiichi Sankyo Co., Ltd.: Honoraria; Chugai Pharmaceutical Co., Ltd.: Honoraria.
2:00 PM

Jenny Paredes, PhD1, Teng Fei, PhD2*, Anqi Dai, MS3*, Ruben Ramos, PhD3*, Peter Adintori, MS3*, Anastasia Kousa, PhD4*, Chi L Nguyen, PhD4*, Kristen Victor3*, Romina Ghale3*, Charlotte Pohl, BA3*, Harold K Elias, MD3,5, Oriana Miltiadous, MD3*, Sebastien Monette6*, Ana Gradissimo, PhD3*, Justin Cross, PhD3*, Jonathan U. Peled, MD, PhD7, Marina Burgos da Silva, PhD8* and Marcel R.M. van den Brink, MD, PhD1

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan Kettering Cancer Center, New York, NY
4City of Hope National Medical Center, Duarte, CA
5National Institutes of Health, Bethesda, MD
6MSKCC, New York, NY
7Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York

2:15 PM

Toru Miyajima, MD1*, Daigo Hashimoto, MD, PhD2*, Keisuke Kojima, MD2*, Shihori Tsukamoto, MD2*, Tomoe Ichiki, MD2*, Yumika Saito, MD2*, Wenyu Li2*, Zixuan Zhang2*, Shinpei Harada, MD2*, Hajime Senjo, MD2, Yuki Yokoi, PhD3*, Yuta Hasegawa, MD, PhD2*, Hiroyuki Ohigashi, MD, PhD2*, Takahide Ara, MD, PhD2*, Kiminori Nakamura, PhD3*, Koji Taniguchi, MD, PhD4* and Takanori Teshima, MD, PhD2

1Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, HOK, Japan
2Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
3Innate Immunity Laboratory, Hokkaido University Faculty of Advanced Life Science, Sapporo, Japan
4Department of Pathology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan

2:30 PM

Jonathan Florentin, PhD*, Alison Moe, PhD*, Ravi K Shah, PhD*, Jacek Zielonka, PhD*, Mark Castleberry, PhD, Alex Myers, BA*, Marlenny Vargas-Cortes, BS*, Jessica L Schmeling, BS*, Anthony E Zamora, PhD* and William R Drobyski, MD

Medical College of Wisconsin, Milwaukee, WI

2:45 PM

Vasantharaja Raguraman, PhD1*, Shanid Mohiyuddin, PhD1*, Catherine Benge, MD2*, Linnea Banker, MD2*, Tyler Plank1*, Richard D Hammer, MD2*, Senthilnathan Palaniyandi, PhD1* and Gerhard C Hildebrandt, MD1

1Department of Medicine, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO
2Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO

3:00 PM

Yuxi Xu, MS1,2*, Ziyi Hu2,3*, Guancui Yang3*, Yuxuan He3*, Qing Xu3*, Ya Zhou3*, Qi Wang3*, Xiaodong Xie3*, Rui Wang3*, Shijie Yang, PhD3*, Xiaoqi Wang, MD3*, Qingxiao Song, MD, PhD2,3 and Xi Zhang, PhD2,4

1Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, AL, China
2Jinfeng Laboratory, Chongqing, China
3Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, China
4Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China

3:15 PM

Sascha Göttert1*, Erik Thiele-Orberg2*, Kaiji Fan1*, Paul Heinrich3*, Daniel Wolff, MD4*, Daniela Weber2*, Florian Bassermann, MD5*, Petra Hoffmann6*, Matthias Edinger, MD7*, Natalie Koehler8*, André Gessner9*, Wolfgang Herr, MD2, Simon M Heidegger, M.D5*, Ernst Holler, MD, PhD2* and Hendrik Poeck, MD2

1University Hospital Regensburg, Regensburg, Germany
2Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
3University of Regensburg, Munich, Germany
4Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Bonn, Germany
5Hospital Rechts der Isar, Internal Medicine III - Hematology and Oncology, Technical University of Munich, Munich, Germany
6University of Regensburg, Regensburg, DEU
7Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, DEU
8Department of Internal Medicine I, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
9Institute of Clinical Microbiology and Hygiene, Regensburg, DEU

*signifies non-member of ASH